I recently attended Medical Week in Baden-Baden, Germany, where I presented the principles of integrative medicine and the latest research on the role of Modified Citrus Pectin in the treatment of cancer. Medical Week is Europe’s biggest medical congress for complementary medicine. The main message I shared with my audience is that integrative medicine and integrative oncology is first about the patient and then about the disease. It’s understanding both and integrating them that allows for profound healing to take place.

Medical Week brought together thousands of healthcare professionals and exhibitors from around the world to share the latest information and advancements in the treatment and prevention of disease. This year’s focus was “Complementary Medicine First!” Dr. Ralph Moss, distinguished lecturer and scientific advisor of the German Oncology Society says, “This annual event is a reminder of just how powerful the movement for integrative medicine is in Germany. It is always heartening for me to return to a country in which complementary medicine is regarded with such great respect.”

During my visit, I had the opportunity to tour several leading cancer clinics in Germany and Austria with Dr. Moss. The trip provided me with a rare opportunity to learn, teach and collaborate with the world’s leading integrative oncologists on ideas for a better future in cancer care. The future of cancer care is, without a doubt, in the true integrative model. At the conference and at the clinics, I shared the energetic and philosophical principles of integrative medicine in oncology and how to apply these principles to cancer prevention and treatment. This included the latest body of research on Modified Citrus Pectin (MCP) and my novel polybotanical formulas in suppressing the growth and proliferation of cancer.

Research on Modified Citrus Pectin and Polybotanicals
During Medical Week, I shared the recent research on the role of Modified Citrus Pectin and polybotanicals in the treatment of cancer. I explained specifically how MCP directly attacks cancer by binding to galectin-3 molecules ("sticky" surface molecules that promote angiogenesis and metastasis) and blocking their ability to promote cancer cell growth and metastasis, among other harmful effects.

Over the last decade, a large body of peer-reviewed research has revealed that many of our most serious health concerns are associated with elevated levels of galectin-3 molecules. Modified Citrus Pectin - derived from citrus peels - is the only proven natural galectin-3 inhibitor and thus offers a powerful, all-natural way to address elevated galectin-3 for cancer, metastasis and other chronic life-threatening illnesses.

For more information about Modified Citrus Pectin, download a complimentary wellness guide by visiting www.mcpreport.com.

Author's Bio: 

Dr. Isaac Eliaz, M.D., MS., L.Ac., has been a pioneer in integrative medicine since the early 1980s. He is a respected researcher, innovative product formulator, clinical practitioner, author and lecturer. Dr. Eliaz is widely regarded as the leading expert in the field of Modified Citrus Pectin research and has been using Modified Citrus Pectin in his clinical practice for over 15 years to treat a variety of conditions.